Long-Term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson'S Disease: A 5-Year Follow-Up Study in China
Lu-Lu Jiang,Jin-Long Liu,Xiao-Li Fu,Wen-Biao Xian,Jing Gu,Yan-Mei Liu,Jing Ye,Jie Chen,Hao Qian,Shao-Hua Xu,Zhong Pei,Ling Chen
DOI: https://doi.org/10.4103/0366-6999.164925
2015-01-01
Abstract:Background: Subthalamic nucleus deep brain stimulation (STN DBS) is effective against advanced Parkinson's disease (PD), allowing dramatic improvement of Parkinsonism, in addition to a significant reduction in medication. Here we aimed to investigate the long-term effect of STN DBS in Chinese PD patients, which has not been thoroughly studied in China.Methods: Ten PD patients were assessed before DBS and followed up 1, 3, and 5 years later using Unified Parkinson's Disease Rating Scale Part III (UPDRS III), Parkinson's Disease Questionnatire-39, Parkinson's Disease Sleep Scale-Chinese Version, Mini-mental State Examination, Montreal Cognitive Assessment, Hamilton Anxiety Scale and Hamilton Depression Scale. Stimulation parameters and drug dosages were recorded at each follow-up. Data were analyzed using the ANOVA for repeated measures.Results: In the "off" state (off medication), DBS improved UPDRS III scores by 35.87% in 5 years, compared with preoperative baseline (P < 0.001). In the "on" state (on medication), motor scores at 5 years were similar to the results of preoperative levodopa challenge test. The quality of life is improved by 58.18% (P < 0.001) from baseline to 3 years and gradually declined afterward. Sleep, cognition, and emotion were mostly unchanged. Levodopa equivalent daily dose was reduced from 660.4 +/- 210.1 mg at baseline to 310.6 +/- 158.4 mg at 5 years (by 52.96%, P < 0.001). The average pulse width, frequency and amplitude at 5 years were 75.0 +/- 18.21 mu s, 138.5 +/- 19.34 Hz, and 2.68 +/- 0.43 V, respectively.Conclusions: STN DBS is an effective intervention for PD, although associated with a slightly diminished efficacy after 5 years. Compared with other studies, patients in our study required lower voltage and medication for satisfactory symptom control.